130 related articles for article (PubMed ID: 8183937)
1. Biologic and therapeutic significance of MYB expression in human melanoma.
Hijiya N; Zhang J; Ratajczak MZ; Kant JA; DeRiel K; Herlyn M; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1994 May; 91(10):4499-503. PubMed ID: 8183937
[TBL] [Abstract][Full Text] [Related]
2. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb.
Melani C; Rivoltini L; Parmiani G; Calabretta B; Colombo MP
Cancer Res; 1991 Jun; 51(11):2897-901. PubMed ID: 2032228
[TBL] [Abstract][Full Text] [Related]
4. Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.
Skorski T; Nieborowska-Skorska M; Nicolaides NC; Szczylik C; Iversen P; Iozzo RV; Zon G; Calabretta B
Proc Natl Acad Sci U S A; 1994 May; 91(10):4504-8. PubMed ID: 8183938
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
[TBL] [Abstract][Full Text] [Related]
6. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.
Jansen B; Wadl H; Inoue SA; Trülzsch B; Selzer E; Duchêne M; Eichler HG; Wolff K; Pehamberger H
Antisense Res Dev; 1995; 5(4):271-7. PubMed ID: 8746776
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells.
Citro G; Szczylik C; Ginobbi P; Zupi G; Calabretta B
Br J Cancer; 1994 Mar; 69(3):463-7. PubMed ID: 8123474
[TBL] [Abstract][Full Text] [Related]
8. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
11. The expression of C-myb in human metastatic melanoma cell lines and specimens.
Walker MJ; Silliman E; Dayton MA; Lang JC
Anticancer Res; 1998; 18(2A):1129-35. PubMed ID: 9615777
[TBL] [Abstract][Full Text] [Related]
12. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.
Sala A; Calabretta B
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10415-9. PubMed ID: 1438227
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
[TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
[TBL] [Abstract][Full Text] [Related]
15. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
16. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines.
Arsura M; Introna M; Passerini F; Mantovani A; Golay J
Blood; 1992 May; 79(10):2708-16. PubMed ID: 1586718
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia.
Gewirtz AM
Leuk Lymphoma; 1993; 11 Suppl 1():131-7. PubMed ID: 7504543
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
Abaza MS; Al-Attiyah RJ; Al-Saffar AM; Al-Sawan SM; Moussa NM
Tumour Biol; 2003; 24(5):241-57. PubMed ID: 15001837
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
Citro G; Perrotti D; Cucco C; D'Agnano I; Sacchi A; Zupi G; Calabretta B
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7031-5. PubMed ID: 1495997
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]